Results were presented in two poster presentations at the Conference on Retroviruses and Opportunistic Infections meeting in to Chronic HIV Subjects Undergoing STI, presents new findings from a Phase 2a clinical trial to assess safety and efficacy of AGS-004 during a 12-week antiretroviral therapy structured treatment interruption in chronic HIV-1 ... (more)
http://ift.tt/1hHKWjM
http://ift.tt/1hHKWjM
No comments:
Post a Comment